Stéphanie Tcherny-Lessenot is the Global Head of Benefit-Risk Evaluation, having served in this role at Sanofi since 2010 after previously working as a Health Outcomes and Pharmacoepidemiology Supervisor at Eli Lilly & Company from 2003 to 2010. Stéphanie has held various leadership positions in Global Pharmacoepidemiology, Epidemiology Operations, and Signal Detection. They earned a degree in public health as a specialist from the University of Paris West, completing their studies in 2003.
Location
Gentilly, France
This person is not in the org chart
This person is not in any teams
This person is not in any offices